全文获取类型
收费全文 | 4393篇 |
免费 | 408篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 91篇 |
妇产科学 | 80篇 |
基础医学 | 700篇 |
口腔科学 | 118篇 |
临床医学 | 420篇 |
内科学 | 1017篇 |
皮肤病学 | 182篇 |
神经病学 | 311篇 |
特种医学 | 281篇 |
外科学 | 662篇 |
综合类 | 60篇 |
一般理论 | 1篇 |
预防医学 | 248篇 |
眼科学 | 42篇 |
药学 | 244篇 |
1篇 | |
中国医学 | 7篇 |
肿瘤学 | 306篇 |
出版年
2022年 | 54篇 |
2021年 | 74篇 |
2020年 | 36篇 |
2019年 | 65篇 |
2018年 | 97篇 |
2017年 | 82篇 |
2016年 | 90篇 |
2015年 | 105篇 |
2014年 | 141篇 |
2013年 | 176篇 |
2012年 | 235篇 |
2011年 | 224篇 |
2010年 | 150篇 |
2009年 | 139篇 |
2008年 | 178篇 |
2007年 | 202篇 |
2006年 | 198篇 |
2005年 | 171篇 |
2004年 | 149篇 |
2003年 | 149篇 |
2002年 | 133篇 |
2001年 | 123篇 |
2000年 | 114篇 |
1999年 | 99篇 |
1998年 | 62篇 |
1997年 | 49篇 |
1996年 | 73篇 |
1995年 | 67篇 |
1994年 | 56篇 |
1993年 | 35篇 |
1992年 | 77篇 |
1991年 | 68篇 |
1990年 | 68篇 |
1989年 | 82篇 |
1988年 | 76篇 |
1987年 | 83篇 |
1986年 | 54篇 |
1985年 | 71篇 |
1984年 | 44篇 |
1983年 | 45篇 |
1981年 | 26篇 |
1980年 | 28篇 |
1979年 | 38篇 |
1978年 | 29篇 |
1976年 | 31篇 |
1975年 | 27篇 |
1974年 | 40篇 |
1973年 | 52篇 |
1972年 | 30篇 |
1969年 | 25篇 |
排序方式: 共有4821条查询结果,搜索用时 15 毫秒
91.
Rivoirard Romain Moncharmont Coralie Assouline Avi Auberdiac Pierre Mery Benoite Falk Alexander Tuan Annède Pierre Trone Jane-Chloé Guy Jean-Baptiste Vial Nicolas Fournel Pierre Merrouche Yacine Chargari Cyrus Magné Nicolas 《European archives of oto-rhino-laryngology》2015,272(3):719-725
European Archives of Oto-Rhino-Laryngology - In the field of radiotherapy, there is very little scientific data on the management of nonagenarians, especially in patients aged 90 years or... 相似文献
92.
93.
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop 总被引:35,自引:0,他引:35
Sharma P McQuaid K Dent J Fennerty MB Sampliner R Spechler S Cameron A Corley D Falk G Goldblum J Hunter J Jankowski J Lundell L Reid B Shaheen NJ Sonnenberg A Wang K Weinstein W;AGA Chicago Workshop 《Gastroenterology》2004,127(1):310-330
BACKGROUND & AIMS: The diagnosis and management of Barrett's esophagus (BE) are controversial. We conducted a critical review of the literature in BE to provide guidance on clinically relevant issues. METHODS: A multidisciplinary group of 18 participants evaluated the strength and the grade of evidence for 42 statements pertaining to the diagnosis, screening, surveillance, and treatment of BE. Each member anonymously voted to accept or reject statements based on the strength of evidence and his own expert opinion. RESULTS: There was strong consensus on most statements for acceptance or rejection. Members rejected statements that screening for BE has been shown to improve mortality from adenocarcinoma or to be cost-effective. Contrary to published clinical guidelines, they did not feel that screening should be recommended for adults over age 50, regardless of age or duration of heartburn. Members were divided on whether surveillance prolongs survival, although the majority agreed that it detects curable neoplasia and can be cost-effective in selected patients. The majority did not feel that acid-reduction therapy reduces the risk of esophageal adenocarcinoma but did agree that nonsteroidal antiinflammatory drugs are associated with a cancer risk reduction and are of promising (but unproven) value. Participants rejected the notion that mucosal ablation with acid suppression prevents adenocarcinoma in BE but agreed that this may be an appropriate strategy in a subgroup of patients with high-grade dysplasia. CONCLUSIONS: Based on this review of BE, the opinions of workshop members on issues pertaining to screening and surveillance are at variance with published clinical guidelines. 相似文献
94.
Brunilda Alushi Frederik Beckhoff David Leistner Marcus Franz Markus Reinthaler Barbara E. Stähli Andreas Morguet Hans R. Figulla Torsten Doenst Francesco Maisano Volkmar Falk Ulf Landmesser Alexander Lauten 《JACC: Cardiovascular Imaging》2019,12(4):591-601
Objectives
The authors investigated the development of pulmonary hypertension (PH), predictors of PH regression, and its prognostic impact on short, mid-, and long-term outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS).Background
PH represents a common finding in patients with AS. Although TAVR is frequently associated with regression of PH, the predictors of reversible PH and its prognostic significance remain uncertain.Methods
In this study, 617 consecutive patients undergoing TAVR between 2009 and 2015 were stratified per baseline tertiles of pulmonary artery systolic pressure (PASP) as follows: normal (PASP <34 mm Hg), mild-to-moderate (PASP ≥34 mm Hg and <46 mm Hg), and severe PASP elevation (PASP ≥46 mm Hg). After TAVR, 520 patients with PH at discharge were stratified according to the presence or absence of PASP reduction. Primary outcome was all-cause mortality at 30 days, 1 year, and long-term follow-up at a maximum of 5.9 years.Results
In patients with both mild-to-moderate and severe PH at baseline, PASP decreased significantly at discharge (ΔPASP 3.0 ± 9.3 mm Hg and 12.0 ± 10.0 mm Hg, respectively) and 1 year (ΔPASP 5.0 ± 9.7 mm Hg and 18.0 ± 14.0 mm Hg, respectively). At a median follow-up of 370 days (interquartile range [IQR]: 84 to 500 days), the risk of all-cause mortality was similar among baseline PASP groups at all time intervals evaluated. After TAVR, a significant regression of PH was observed in 46% of patients. Contrarily, patients with residual PH had a higher risk of all-cause mortality at 30 days (hazard ratio [HR]: 3.49, 95% confidence interval [CI]: 1.74 to 6.99; p < 0.001), 1 year (HR: 3.12, 95% CI: 2.06 to 4.72; p < 0.001), and long-term (HR: 2.47, 95% CI: 1.74 to 3.49; p < 0.001). Left ventricular ejection fraction (LVEF) >40% (odds ratio [OR]: 3.56, 95% CI: 2.24 to 5.65; p < 0.001), baseline PASP ≥46 mm Hg (OR: 3.26, 95% CI: 2.07 to 5.12; p < 0.001), absence of concomitant tricuspid regurgitation (TR) ≥ moderate (OR: 0.53, 95% CI: 0.34 to 0.84; p < 0.001), and logistic EuroSCORE <25% (OR: 1.59, 95% CI: 1.04 to 2.45; p = 0.03) were independent predictors of PASP reduction.Conclusions
In most patients with PH and AS, TAVR is associated with a significant early and late reduction of PASP. Patients with reversible PH after TAVR are at lower risk of all-cause mortality at early, mid-, and long-term follow-up. Therefore, the presence of PH should not preclude treatment with TAVR. 相似文献95.
Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening 总被引:4,自引:0,他引:4
Juan Jose Badimon Antonio Fernandez Ortiz Beat Meyer Alessandra Mailhac John T Fallon Erling Falk Lina Badimon James H Chesebro Valentin Fuster 《Atherosclerosis》1998,140(2):307-314
PTCA is a well-established intervention to reduce the severity of atherosclerotic coronary stenosis. Its primary success rate is seriously handicapped by the high incidence of late restenosis. Given the clinical and social importance of this proliferative process, new strategies are needed to prevent or reduce restenosis. Several animal models as well as different arteries have been used to study neointimal proliferation after arterial injury. A number of agents have shown to reduce neointimal proliferation after arterial injury in the carotids and iliac arteries of rodent models. Unfortunately, these results have not been replicated in humans. We have compared the acute and late response to vascular injury of the carotid and coronary arteries in the pig. Arterial injury was induced by performing balloon angioplasty of the carotid (elastic) and coronary (muscular) arteries in swine. Acute platelet-thrombus formation was evaluated by quantitation of Indium-labeled platelets deposited on the injured segments 1 h after procedure. Measurement of intimal area was performed by morphometry of the most stenotic cross-section at 28 days after balloon angioplasty. Platelet deposition after mild and severe injury in carotids (4±1 and 56±13×106 platelets/cm2, respectively) and coronaries (15±5 and 141±20×106 platelets/cm2, respectively) are significantly greater in deep, than in mild injury (P<0.005), and significantly greater in coronary than in carotid arteries after deep injury (P<0.05). Likewise, late neointima formation was significantly greater (P<0.05) after mild and severe injury in coronary (17±0.5 and 56 ±2%, respectively) than in carotid arteries (5±0.5 and 12±1%, respectively). Acute platelet-thrombus formation and late neointimal thickening are modulated by the degree of injury induced during the interventions; and after disruption of the internal elastic lamina, coronary arteries always had significantly more acute thrombus and neointimal thickening. This study emphasizes the importance of the animal species, the type of injury and the artery chosen for studies on restenosis post interventions. 相似文献
96.
Dr. Doris H. B. Palvio M.D. Erik Steen Kristensen M.D. Erling Falk M.D. 《Diseases of the colon and rectum》1985,28(10):746-748
A case of a carcinoid tumor arising in a Meckel's diverticulum is reported. By the time of detection, the tumor had spread
to the mesentery causing ischemia of the small intestine due to the associated vascular elastosis. 相似文献
97.
Ming Jiang Wei-Yao Ku Zhongren Zhou Evan S. Dellon Gary W. Falk Hiroshi Nakagawa Mei-Lun Wang Kuancan Liu Jun Wang David A. Katzka Jeffrey H. Peters Xiaopeng Lan Jianwen Que 《The Journal of clinical investigation》2015,125(4):1557-1568
Tissue homeostasis requires balanced self-renewal and differentiation of stem/progenitor cells, especially in tissues that are constantly replenished like the esophagus. Disruption of this balance is associated with pathological conditions, including eosinophilic esophagitis (EoE), in which basal progenitor cells become hyperplastic upon proinflammatory stimulation. However, how basal cells respond to the inflammatory environment at the molecular level remains undetermined. We previously reported that the bone morphogenetic protein (BMP) signaling pathway is critical for epithelial morphogenesis in the embryonic esophagus. Here, we address how this pathway regulates tissue homeostasis and EoE development in the adult esophagus. BMP signaling was specifically activated in differentiated squamous epithelium, but not in basal progenitor cells, which express the BMP antagonist follistatin. Previous reports indicate that increased BMP activity promotes Barrett’s intestinal differentiation; however, in mice, basal progenitor cell–specific expression of constitutively active BMP promoted squamous differentiation. Moreover, BMP activation increased intracellular ROS levels, initiating an NRF2-mediated oxidative response during basal progenitor cell differentiation. In both a mouse EoE model and human biopsies, reduced squamous differentiation was associated with high levels of follistatin and disrupted BMP/NRF2 pathways. We therefore propose a model in which normal squamous differentiation of basal progenitor cells is mediated by BMP-driven NRF2 activation and basal cell hyperplasia is promoted by disruption of BMP signaling in EoE. 相似文献
98.
Raimund HM Preidl Tobias Ebker Martin Raithel Falk Wehrhan Friedrich W Neukam Philipp Stockmann 《BMC gastroenterology》2014,14(1):1-6
Background
Cyclooxygenase-2 (COX-2, PTGS2) is an enzyme involved in the synthesis of prostaglandins and thromboxanes, which are regulators of biologic processes such as inflammation, cell proliferation and angiogenesis. COX-2 over-expression was reported in many (pre) malignant tissues, but data strongly vary and seem to depend on the methodology used.Methods
Normal colorectal mucosa and paired cancerous tissue from 60 patients with colorectal cancer was investigated for the levels of COX-2 mRNA by real-time quantitative Polymerase Chain Reaction (qPCR). COX-2 levels were expressed relative to either: tissue weight or levels of the housekeeping genes beta-2 microglobulin (B2M) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).Results
COX-2 mRNA levels, normalized with respect to tissue weight or mRNA levels of the housekeeping genes B2M or GAPDH, were over-expressed in 80%, 70% and 40% of the colorectal tumor tissues, as compared to the paired adjacent normal colorectal mucosa samples, respectively. Highest mRNA COX-2 ratios tumor/normal were measured when expressed per mg tissue (mean ratio 21.6). When normalized with respect to the housekeeping genes B2M or GAPDH, mean tumor/normal ratios were 16.1 and 7.5, respectively.Conclusion
Expression of COX-2 mRNA levels per mg tissue is most simple in comparison to normalization with respect to the housekeeping genes B2M or GAPDH. Levels of COX-2 mRNA are found over-expressed in almost 80% of the colorectal tumors, compared to paired adjacent normal colorectal mucosa, suggesting a role of COX-2 as a potential biomarker for cancer risk, whereas inhibitors of COX-2 could be of value in chemoprevention of colon cancer. 相似文献99.
Taewoo Lee Adil Gasim Vimal K. Derebail Yunro Chung JulieAnne G. McGregor Sophia Lionaki Caroline J. Poulton Susan L. Hogan J. Charles Jennette Ronald J. Falk Patrick H. Nachman 《Clinical journal of the American Society of Nephrology》2014,9(5):905-913
Background and objectives
In ANCA-associated GN, severe renal dysfunction portends a poor prognosis for renal recovery and patient survival. This study evaluated the prognostic factors affecting renal and patient outcomes in patients presenting with severe kidney failure to guide immunosuppressive therapy.Design, setting, participants, & measurements
This study retrospectively evaluated clinical and histopathologic characteristics of 155 patients who underwent biopsy between October 1985 and February 2011 (median eGFR at presentation, 7.1 ml/min per 1.73 m2; 87% required hemodialysis), all treated with immunosuppressive medications. Three outcomes of interest were measured: patient survival, renal survival, and treatment response (defined as dialysis-free survival without active vasculitis by 4 months after biopsy). Competing risk, Cox, and logistic regression analyses were conducted for each outcome measure.Results
Within 4 months after biopsy, treatment response was attained in 51% of patients, 35% remained on dialysis, and 14% died. In a competing risk analysis, estimated cumulative incidence rates of ESRD and disease-related mortality were 26% and 17% at 1 year and 32% and 28% at 5 years, respectively. Cyclophosphamide therapy and treatment response by 4 months were independently associated with patient and renal survival, adjusting for the percentage of normal glomeruli, histopathologic chronicity index score, and baseline clinical characteristics. Only 5% of patients still dialysis dependent at 4 months subsequently recovered renal function. Low chronicity index score (odds ratio [OR], 1.16; 95% confidence interval [95% CI], 1.04 to 1.30, per unit decrease) and baseline eGFR>10 ml/min per 1.73 m2 (OR, 2.77; 95% CI, 1.09 to 7.01) were significantly associated with treatment response by 4 months. Among cyclophosphamide-treated patients, the likelihood of treatment response was >14% even with highest chronicity index score and eGFR<10 ml/min per 1.73 m2.Conclusions
Although low baseline renal function and severe renal scarring are associated with lower treatment response rate, no “futility” threshold could be identified. Conversely, continued immunosuppressive therapy beyond 4 months is unlikely to benefit patients who remain dialysis dependent. 相似文献100.